As a 25% shareholder in Expertech, SNC-Lavalin, along with Bell Canada, would like to express its regret at the decision announced today by Expertech's unionized employees to reject their management's final offer to restructure their services. Expertech is left with no other solution than to develop a plan for an orderly winding down of its operations.

SNC-Lavalin Group Inc. (TSX:SNC) announced its fourth quarter and year-end results with growth in net income and revenues, as well as a 29% dividend increase.

Assard-ELD (Architecture) and SNC-Lavalin Pharma (Special Technology) recently completed the design, construction management and certification of buildings (110,000 m2) for the new vaccine quality control centre that GlaxoSmithKline (GSK) - the world's second largest pharmaceutical company - had built in Wavre, Belgium.

SNC-Lavalin is pleased to announce that it has acquired two companies, The Construction Partnership, Inc. (TCPI) and NorthStar CV, Inc., both based in the State of Pennsylvania, USA. These acquisitions increase SNC-Lavalin's pharmaceutical and biotechnology team by about 50 people to over 700 employees worldwide.